Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate Augmentation in SRI-Refractory OCD
NCT00182520Phase 4Completed
- Sponsor
- McMaster University
- Start
- Jan 2002
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Topiramate with placebo (2 arms). Primary endpoints: Yale-Brown Obsessive Compulsive Scale at 12 weeks and Clinical Global Impression - Improvement at 12 weeks. Started Jan 2002; status: completed.
02
Drugs
topiramate
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00182520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182520.